Nippon Shinyaku (NPNKF) Stock Price, News & Analysis

Company Overview

Nippon Shinyaku Co., Ltd. operates as a research-driven pharmaceutical company headquartered in Kyoto, Japan. It specializes in the discovery, development, manufacture and marketing of therapeutic drugs across multiple therapeutic areas, including urology, hematology, oncology and internal medicine. The company’s business model integrates in-house research capabilities with strategic collaborations to bring novel small-molecule and biologic products to market.

Established in 1909 by entrepreneur Yorisuke Tsuji, Nippon Shinyaku has evolved from a domestic manufacturer into a global healthcare enterprise. While its primary market remains Japan, the company has expanded its geographic footprint with subsidiaries and joint ventures in Europe and North America to support clinical development and commercialization. Manufacturing facilities are located primarily in Kyoto and Tsukuba, where quality control and regulatory compliance are core priorities.

Key products include treatments for benign prostatic hyperplasia, anemia and chemotherapeutic support agents, alongside a growing portfolio of biosimilars and specialty pharmaceuticals. Nippon Shinyaku also offers contract development and manufacturing services for active pharmaceutical ingredients. Backed by a pipeline of early- and late-stage candidates, the company invests in advanced research platforms aimed at addressing unmet medical needs and enhancing patient outcomes worldwide.

Key Stats

• Today's Range: $31.40 to $31.40
• 50-Day Range: $31.40 to $32.00
• 52-Week Range: $31.40 to $32.00
• Volume: N/A
• Average Volume: 371 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:NPNKF
• CIK: N/A
• Web: www.nippon-shinyaku.co.jp
• Phone: 81-7-5321-1111
• Fax: N/A
• Employees: 2,213
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A